Earlybird Venture Capital at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Earlybird Venture Capital takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions cover the state of early-stage biotech investment and how AI and digital collaboration are changing drug discovery. The investment session is shared with the European Innovation Council, Eir Ventures and Sofinnova Partners.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Earlybird Venture Capital Berlin, Germany | |
European venture capital firm investing in technology and health companies. | Panel Mon Nov 9 16:00–16:45 Fuelling Innovation: The State of Early-Stage Investment in Biotech Investors and founders discuss how young biotech startups raise early funding today and how venture investors' priorities are shifting. Panel Wed Nov 11 13:00–13:45 AI-Powered Ecosystems: Transforming Drug Discovery Through Digital Collaboration How drug, biotech and tech companies can build AI partnerships, and why AI finds easier wins in early discovery than in later clinical stages. |
Instantly find 20 buyers from Earlybird Venture Capital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction